Lyndra Therapeutics

Lyndra Therapeutics company information, Employees & Contact Information

Explore related pages

Lyndra Therapeutics email format Lyndra Therapeutics management contacts

Related company profiles:

As of March 26, 2025, Lyndra Therapeutics has ceased operations. Please direct any inquiries by email to Craig Jalbert at cjalbert@vlpc.com.

Company Details

Employees
32
Founded
-
Address
65 Grove St, Suite 301,united States
Phone
+1-857-304-4512
Email
in****@****dra.com
Industry
Biotechnology
Website
lyndra.com
Keywords
Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies.
HQ
Watertown, Massachusetts
Competitors
ElevateBio, Vivtex, Beam Therapeutics, Verve Therapeutics, Sarepta Therapeutics, LifeMine Therapeutics, Lyra Therapeutics, Syntis Bio, Carisma Therapeutics, Vertex Pharmaceuticals.
Looking for a particular Lyndra Therapeutics employee's phone or email?

Lyndra Therapeutics Questions

News

Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO - Yahoo Finance

Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO Yahoo Finance

Langer spinout Lyndra Therapeutics begins winding down operations, lays off staff - Fierce Biotech

Langer spinout Lyndra Therapeutics begins winding down operations, lays off staff Fierce Biotech

Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies - Business Wire

Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies Business Wire

Ultra long‐acting oral therapies for Alzheimer's: Proof of principle - Wiley

Ultra long‐acting oral therapies for Alzheimer's: Proof of principle Wiley

Lyndra and Thermo Fisher partner for oral therapies - Pharmaceutical Technology

Lyndra and Thermo Fisher partner for oral therapies Pharmaceutical Technology

Lyndra taps Thermo Fisher to help with research, commercial production of long-acting oral meds - Fierce Pharma

Lyndra taps Thermo Fisher to help with research, commercial production of long-acting oral meds Fierce Pharma

Lyndra Therapeutics Signs Manufacturing Agreement with Thermo for Long-Acting Oral Therapies - Genetic Engineering and Biotechnology News

Lyndra Therapeutics Signs Manufacturing Agreement with Thermo for Long-Acting Oral Therapies Genetic Engineering and Biotechnology News

Lyndra Therapeutics Completes $60.5 Million Series C Financing - Daily Freeman

Lyndra Therapeutics Completes $60.5 Million Series C Financing Daily Freeman

Biotech spinout from MIT's Langer Lab winds down operations - The Business Journals

Biotech spinout from MIT's Langer Lab winds down operations The Business Journals

This company wants to make a once-a-month option for birth control pills - statnews.com

This company wants to make a once-a-month option for birth control pills statnews.com

Lyndra Therapeutics appoints Jenkins, Fernandes to executive roles - Drug Delivery Business

Lyndra Therapeutics appoints Jenkins, Fernandes to executive roles Drug Delivery Business

Gilead-backed Lyndra Therapeutics cuts nearly a quarter of staff as ph. 3 data near - Fierce Pharma

Gilead-backed Lyndra Therapeutics cuts nearly a quarter of staff as ph. 3 data near Fierce Pharma

Lyndra Therapeutics Raises $101 Million in Series E Funding - Business Wire

Lyndra Therapeutics Raises $101 Million in Series E Funding Business Wire

Lyndra Therapeutics Announces Positive Data from Pivotal Phase 3 Study with Oral Weekly Risperidone (LYN-005) for Schizophrenia - Business Wire

Lyndra Therapeutics Announces Positive Data from Pivotal Phase 3 Study with Oral Weekly Risperidone (LYN-005) for Schizophrenia Business Wire

Lyndra Therapeutics Announces Leadership Changes, Update on Pivotal Trial Progress - Business Wire

Lyndra Therapeutics Announces Leadership Changes, Update on Pivotal Trial Progress Business Wire

Lyndra Therapeutics Appoints Abigail Jenkins as Chief Commercial and Business Officer and Jacqueline Fernandes as Vice President of Data Compliance and Information Technology - Business Wire

Lyndra Therapeutics Appoints Abigail Jenkins as Chief Commercial and Business Officer and Jacqueline Fernandes as Vice President of Data Compliance and Information Technology Business Wire

Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder - Business Wire

Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder Business Wire

Lyndra extends shelf life of its Lynx oral drug delivery platform - BioWorld MedTech

Lyndra extends shelf life of its Lynx oral drug delivery platform BioWorld MedTech

Lyndra banks $60.5M to bring ultralong-acting pill into pivotal schizophrenia trial - Fierce Biotech

Lyndra banks $60.5M to bring ultralong-acting pill into pivotal schizophrenia trial Fierce Biotech

Lyndra's ultralong-acting pill shows promise in schizophrenia phase 2, teeing up pivotal trial - Fierce Biotech

Lyndra's ultralong-acting pill shows promise in schizophrenia phase 2, teeing up pivotal trial Fierce Biotech

Gilead partners with Lyndra to create long-acting oral HIV drugs - Pharmaceutical Technology

Gilead partners with Lyndra to create long-acting oral HIV drugs Pharmaceutical Technology

Lyndra Therapeutics raises $55 million from Gilead and Gates - statnews.com

Lyndra Therapeutics raises $55 million from Gilead and Gates statnews.com

Lyndra Therapeutics bags $13M Gates grant to develop once-monthly contraceptive pill - Fierce Biotech

Lyndra Therapeutics bags $13M Gates grant to develop once-monthly contraceptive pill Fierce Biotech

One pill a month? Breakthrough may reinvent medicine - The Charlotte Post

One pill a month? Breakthrough may reinvent medicine The Charlotte Post

Gilead and Lyndra Team Up to Develop Long-Acting HIV Therapies - BioSpace

Gilead and Lyndra Team Up to Develop Long-Acting HIV Therapies BioSpace

Lyndra lands $105m deal with Allergan for once-weekly Alzheimer’s drugs - Drug Delivery Business

Lyndra lands $105m deal with Allergan for once-weekly Alzheimer’s drugs Drug Delivery Business

A 'once a month' birth control pill - News-Medical

A 'once a month' birth control pill News-Medical

Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 mn - Business Standard

Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 mn Business Standard

Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 million - Business Today

Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 million Business Today

Companies like Lyndra Therapeutics

Carisma Therapeutics logo - Similar company to Lyndra Therapeutics

Carisma Therapeutics

35
Lyra Therapeutics logo - Similar company to Lyndra Therapeutics

Lyra Therapeutics

41
Vertex Pharmaceuticals logo - Similar company to Lyndra Therapeutics

Vertex Pharmaceuticals

6.09K
ElevateBio logo - Similar company to Lyndra Therapeutics

Elevatebio

531
Syntis Bio logo - Similar company to Lyndra Therapeutics

Syntis Bio

17
LifeMine Therapeutics logo - Similar company to Lyndra Therapeutics

Lifemine Therapeutics

54
Vivtex logo - Similar company to Lyndra Therapeutics

Vivtex

18
Beam Therapeutics logo - Similar company to Lyndra Therapeutics

Beam Therapeutics

557
Sarepta Therapeutics logo - Similar company to Lyndra Therapeutics

Sarepta Therapeutics

1.37K
Verve Therapeutics logo - Similar company to Lyndra Therapeutics

Verve Therapeutics

309

Top Lyndra Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant